$300M Stock Offering Priced at $27 by IDEAYA, Below Market
IDYA sits 41% above its 52-week low of $20.5 on elevated volume (2.2× avg).
Summary
IDEAYA Biosciences priced a $300 million common stock offering at $27 per share, a discount to its current trading price. This capital raise, which represents over 10% of the company's market value, will dilute existing shareholders. The offering follows a 424B5 filing yesterday that announced the launch of the public offering. This financing is expected to fund the company's ongoing clinical development, building on recent positive Phase 2/3 trial results for darovasertib and new strategic partnerships.
At the time of this announcement, IDYA was trading at $28.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $20.50 to $39.28. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.